Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems

被引:20
作者
Lin, Yu Kuei [1 ]
Groat, Danielle [2 ]
Chan, Owen [1 ]
Hung, Man [3 ]
Sharma, Anu [1 ]
Varner, Michael W. [4 ]
Gouripeddi, Ramkiran [2 ]
Facelli, Julio C. [2 ]
Fisher, Simon J. [1 ]
机构
[1] Univ Utah, Sch Med, Dept Internal Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA
[2] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Study Design & Biostat Ctr, Ctr Clin & Translat Sci, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA
关键词
Hypoglycemia; Impaired awareness of hypoglycemia; Continuous glucose monitoring; Type; 1; diabetes; IMPAIRED AWARENESS; GLYCEMIC THRESHOLDS; INSULIN INJECTIONS; AUTONOMIC FAILURE; ADULTS; COUNTERREGULATION; MULTICENTER; CONSENSUS; SYMPTOMS;
D O I
10.1089/dia.2020.0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods:For this cross-sectional observational study, 99 T1D patients using real-time CGMs for >= 86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results:IAH was associated with greater percentages of CGM values <70 and <54 mg/dL (P = 0.012,P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL (P = 0.013,P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at >= 1 time point (P = 0.048,P = 0.003) or lasting >= 20 min (P = 0.016,P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL (P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL (P = 0.009,P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL (P < 0.001,P = 0.006), respectively. Conclusions:T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 40 条
[1]   Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange [J].
Agiostratidou, Gina ;
Anhalt, Henry ;
Ball, Dana ;
Blonde, Lawrence ;
Gourgari, Evgenia ;
Harriman, Karen N. ;
Kowalski, Aaron J. ;
Madden, Paul ;
McAuliffe-Fogarty, Alicia H. ;
McElwee-Malloy, Molly ;
Peters, Anne ;
Raman, Sripriya ;
Reifschneider, Kent ;
Rubin, Karen ;
Weinzimer, Stuart A. .
DIABETES CARE, 2017, 40 (12) :1622-1630
[2]   Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions [J].
Amiel, Stephanie A. ;
Choudhary, Pratik ;
Jacob, Peter ;
Smith, Emma Lauretta ;
De Zoysa, Nicole ;
Gonder-Frederick, Linda ;
Kendall, Mike ;
Heller, Simon ;
Brooks, Augustin ;
Toschi, Elena ;
Kariyawasam, Dulmini ;
Potts, Laura ;
Healy, Andy ;
Rogers, Helen ;
Sevdalis, Nick ;
Stadler, Marietta ;
Qayyum, Mustabshira ;
Bakolis, Ioannis ;
Goldsmith, Kimberley .
BMJ OPEN, 2019, 9 (06)
[3]   Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes [J].
Amiel, Stephanie A. ;
Aschner, Pablo ;
Childs, Belinda ;
Cryer, Philip E. ;
de Galan, Bastiaan E. ;
Heller, Simon R. ;
Frier, Brian M. ;
Gonder-Frederick, Linda ;
Jones, Timothy ;
Khunti, Kamlesh ;
Leiter, Lawrence A. ;
McCrimmon, Rory J. ;
Luo, Yingying ;
Seaquist, Elizabeth R. ;
Vigersky, Robert ;
Zoungas, Sophia .
DIABETOLOGIA, 2017, 60 (01) :3-6
[4]   Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes - Reduced awakening from sleep during hypoglycemia [J].
Banarer, S ;
Cryer, PE .
DIABETES, 2003, 52 (05) :1195-1203
[5]   Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].
Battelino, Tadej ;
Danne, Thomas ;
Bergenstal, Richard M. ;
Amiel, Stephanie A. ;
Beck, Roy ;
Biester, Torben ;
Bosi, Emanuele ;
Buckingham, Bruce A. ;
Cefalu, William T. ;
Close, Kelly L. ;
Cobelli, Claudio ;
Dassau, Eyal ;
DeVries, J. Hans ;
Donaghue, Kim C. ;
Dovc, Klemen ;
Doyle, Francis J. ;
Garg, Satish ;
Grunberger, George ;
Heller, Simon ;
Heinemann, Lutz ;
Hirsch, Irl B. ;
Hovorka, Roman ;
Jia, Weiping ;
Kordonouri, Olga ;
Kovatchev, Boris ;
Kowalski, Aaron ;
Laffel, Lori ;
Levine, Brian ;
Mayorov, Alexander ;
Mathieu, Chantal ;
Murphy, Helen R. ;
Nimri, Revital ;
Norgaard, Kirsten ;
Parkin, Christopher G. ;
Renard, Eric ;
Rodbard, David ;
Saboo, Banshi ;
Schatz, Desmond ;
Stoner, Keaton ;
Urakami, Tatsuiko ;
Weinzimer, Stuart A. ;
Phillip, Moshe .
DIABETES CARE, 2019, 42 (08) :1593-1603
[6]   Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial [J].
Beck, Roy W. ;
Riddlesworth, Tonya ;
Ruedy, Katrina ;
Ahmann, Andrew ;
Bergenstal, Richard ;
Haller, Stacie ;
Kollman, Craig ;
Kruger, Davida ;
McGill, Janet B. ;
Polonsky, William ;
Toschi, Elena ;
Wolpert, Howard ;
Price, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04) :371-378
[8]   Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes [J].
Bednarik, Petr ;
Moheet, Amir A. ;
Grohn, Heidi ;
Kumar, Anjali F. ;
Eberly, Lynn E. ;
Seaquist, Elizabeth R. ;
Mangia, Silvia .
FRONTIERS IN NEUROSCIENCE, 2017, 11
[9]   Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019 [J].
Cefalu, William T. ;
Berg, Erika Gebel ;
Saraco, Mindy ;
Petersen, Matthew P. ;
Uelmen, Sacha ;
Robinson, Shamera .
DIABETES CARE, 2019, 42 :S90-S102
[10]  
Childs BP, 2005, DIABETES CARE, V28, P1245